Central coverage decisions can feel like rationing
When one public body decides which treatments are covered or worth their price, every 'no' becomes a national controversy, and patients have no other insurer to turn to.
Evidence
- NICE in the UK applies cost-per-QALY thresholds and has faced public disputes over declined drugs.
Who's affected
- People with ongoing or specialist care needs: People needing a declined or delayed treatment have no other insurer to turn to.
- Drug and device makers: A declined product loses the whole national market.
- Taxpayers and public budgets: Declining low-value care holds down public spending.
Under your mix of paths
- Finite budget with one decision-maker
Open questions
- How should coverage decisions be made, appealed, and balanced against cost?
Caused or worsened by these paths
This problem only matters if one of these paths is chosen.
One public body decides what is covered for everyone, so each 'no' applies nationwide.
Public coverage decisions move refusals from individual claims to program-wide rules.
A national negotiating body uses value assessments as benchmarks for drug prices, placing those assessments within a national decision process.
Drug pricing depends on assessments of added benefit, with disputes over how that value should be measured.
A public body deciding which services to stop covering can generate controversy over coverage decisions.
Coverage assessment delays some new treatments while avoiding payment for unproven drugs.
Solution paths (3)
Open a path for what it fixes, what it creates or worsens, who gains and who loses, precedents, and how it connects to other paths. See all paths as a decision tree.
An arm's-length agency evaluates evidence and cost in public meetings with patient representatives, publishes reasons, and allows appeals and reconsideration when new evidence appears.
- +Central coverage decisions can feel like rationing
- −Takes years, or money up front, before it pays off
Ban cost-per-QALY thresholds; cover any treatment shown to work and control cost through price negotiation instead.
- +Central coverage decisions can feel like rationing
- +Claim denials
- −Chronic underfunding by government budgets
- −Raises spending or loosens control over it
Clinicians can request coverage for individual patients outside the standard list, decided within days by a clinical panel.
- +Central coverage decisions can feel like rationing
- −Racial, income, and geographic disparities